Ko 143
Cat. No.：YN360004
CAS No. ：461054-93-3
| 产品名称: | Ko 143 |
| CAS No.: | 461054-93-3 |
| Chemical Name: | (3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxo-pyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester |
| Synonyms: | tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)propanoate;Ko 143;Ko143 hydrate;tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7, 12,12a-octahydropyrazin |
| 分子量: | 469.57 |
| 分子式: | C₂₆H₃₅N₃O₅ |
| SMILES: | O=C1N2[C@]([H])(C3=C(C[C@]2(C(N[C@H]1CCC(OC(C)(C)C)=O)=O)[H])C4=CC=C(OC)C=C4N3)CC(C)C |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Ko 143 是有效且选择性的 ATP 结合盒亚家族 G 成员 2 (ABCG2/BCRP) 抑制剂。Ko 143 比 P-gp 和 MRP-1 运输蛋白高出 200 倍的选择性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Matsuo, H., Takada, T., Ichida, K., et al.Common defects of ABCG2, a high-capacity urate exporter, cause gout: A function-based genetic analysis in a Japanese populationSci. Transl. Med.1(5),1-9(2009)
Allen, J.D., van Loevezijn, A., Lakhai, J.M., et al.Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin CMol. Cancer Ther.1(6),417-425(2002)
Wanek, T., Kuntner, C., Bankstahl, J.P., et al.A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrierJ. Cereb. Blood Flow Metab.32(11),2002-2011(2012)
